CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.0) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS
RSC Advances
Page 8 of 11
ARTICLE TYPE
DOI: 10.1039/C4RA16568C
8.52Hz, 1H), 7.99 (dd, J=1.84, 6.8Hz, 2H), 7.53ꢀ7.46 (m, 3H),
142.30, 141.20, 130.14, 129.39, 129.26, 129.07, 129.01,
6.81ꢀ6.72 (m, 2H), 4.76 (d, J=4.4Hz, 2H); 13C NMR (CDCl3, 60 128.95,114.56, 55.41; MS (ESI) m/z: 237 (M+H)+.
100MHz, TMS) δ: 191.64, 143.86, 140.80, 138.96, 136.24,
129.45, 129.30, 127.17, 116.17, 114.05, 49.43; MS (APCI) m/z:
291 (M+H)+. HRMS (ESI) m/z calcd for C14H11ClN2O3Na+
[M+Na+], 313.0350; Found 313.0349.
2ꢀ(3ꢀMethoxyphenyl)quinoxaline (Table 8, Entry 3)5k: Light
yellowish orange solid (198 mg, 84 %); mp = 87ꢀ88 °C; IR (KBr)
max = 3434, 2918, 2846, 2225, 1733, 1275, 1260, 1022, 750 cmꢀ
5
1
1; H NMR (CDCl3, 400MHz, TMS) δ: 9.36 (s, 1H), 8.19ꢀ8.13
2ꢀ[(4ꢀChloroꢀ2ꢀnitrophenyl)amino]ꢀ1ꢀphenylethanone (Table 65 (m, 2H), 7.92 (dd, J=1.8,7.64 Hz, 1H), 7.80ꢀ7.74 (m, 2H), 7.52ꢀ
3, Entry 3): Yellow solid (258 mg, 89 %); mp = 158ꢀ160 °C; IR
7.48 (m, 1H), 7.22ꢀ7.17 (m, 1H), 7.09 (d, J=8.24 Hz, 1H), 3.93 (s,
3H); 13C NMR (CDCl3, 100MHz, TMS) δ: 157.40, 152.23,
147.30, 142.71, 141.06, 131.61, 131.44, 129.76, 129.55, 129.37,
129.07,126.56, 121.54, 111.43, 55.65; MS (ESI) m/z: 237
(KBr)
= 3342, 3005.58, 1691, 1628, 1561.90, 1517, 1402,
max
10 1351, 1275, 1261,1156, 1070, 808, 764, 750 cmꢀ1;1H NMR
(CDCl3, 400MHz, TMS) δ: 8.89 (bs, 1H), 8.24 (d, J=2.36Hz,
1H), 8.04 (d, J=7.52Hz, 2H), 7.67 (t, J=7.4Hz, 1H), 7.55 (t, 70 (M+H)+.
J=7.76Hz, 2H), 7.44 (dd, J=2.36, 9.04Hz, 1H), 6.79 (d,
J=9.04Hz, 1H), 4.77 (d, J=4.24Hz, 2H); 13C NMR (CDCl3,
15 100MHz, TMS) δ: 192.30, 142.62, 136.28, 134.38, 134.30,
129.11, 127.92, 126.32, 120.83, 115.54, 49.44; MS (APCI) m/z:
2ꢀ(4ꢀChlorophenyl)quinoxaline (Table 8, Entry 4)4a: Light
orange solid (197 mg, 82 %); mp = 120ꢀ122 °C; IR (KBr)
=
max
3004, 2325, 1260, 1275, 764, 750 cmꢀ1; 1H NMR (CDCl3,
400MHz, TMS) δ: 9.31 (s, 1H), 8.19ꢀ8.13 (m, 4H), 7.83ꢀ7.75 (m,
291 (M+H)+. HRMS (ESI) m/z calcd for C14H11ClN2O3Na+ 75 2H), 7.57ꢀ7.54 (m, 2H); 13C NMR (CDCl3, 100MHz, TMS) δ:
[M+Na+], 313.0350; Found 313.0350.
150.59, 142.87, 142.22, 141.66, 136.59, 135.19, 130.48, 129.79,
129.60, 129.41, 129.17, 128.78; MS (ESI) m/z: 241 (M+H)+.
2ꢀ(4ꢀBromophenyl)quinoxaline (Table 8, Entry 5)5k: Light
brown solid (238 mg, 84 %); mp = 138 °C; 1H NMR (CDCl3, 400
2ꢀ[(5ꢀChloroꢀ2ꢀnitrophenyl)amino]ꢀ1ꢀphenylethanone (Table
20 3, Entry 4): Yellow solid (262 mg, 90 %); mp = 155ꢀ158 °C; IR
(KBr) max = 3362, 2924, 1695, 1623, 1491, 1275, 1259, , 1078,
1
750 cmꢀ1; H NMR (CDCl3, 400MHz, TMS) δ: 9.00 (bs, 1H), 80 MHz, TMS) δ: 9.29 (s, 1H), 8.15ꢀ8.07 (m, 4H), 7.82ꢀ7.74 (m,
8.20 (d, J=9.08Hz, 1H), 8.06 (d, J=1.2Hz, 2H), 7.69 (t, J=7.44Hz,
1H), 7.57 (t, J=8Hz, 2H), 6.84 (d, J=1.96Hz, 1H), 6.72 (dd, J=2,
25 9.14Hz, 1H), 4.78 (d, J=4.28Hz, 2H); 13C NMR (CDCl3,
100MHz, TMS) δ: 192.12, 144.41, 142.70, 134.41, 134.23,
2H), 7.71ꢀ7.68 (m, 2H); 13C NMR (CDCl3, 100MHz, TMS) δ:
150.66, 142.83, 142.22, 141.68, 135.62, 132.80, 130.37, 131.88,
130.52, 129.84, 129.60,129.18, 129.02, 125.00; MS (ESI) m/z:
284 (M+H)+.
130.17, 129.28, 129.11, 128.52, 128.32, 127.96, 116.48, 113.71 85 7ꢀChloroꢀ2ꢀphenylquinoxaline (Table 8, Entry 6)5i: Light
49.39; MS (ESI) m/z: 291 (M+H)+. HRMS (ESI) m/z calcd for
C14H11ClN2O3Na+ [M+Na+], 313.0350; Found 312.1499.
30 2ꢀ[(4ꢀMethylꢀ2ꢀnitrophenyl)amino]ꢀ1ꢀphenylethanone (Table
3, Entry 5): Light yellow solid (248 mg, 92 %); mp = 162ꢀ164
orange solid (194 mg, 81 %); mp = 104ꢀ106 °C; IR (KBr)
=
max
3047, 2922, 2852. 1606, 1539, 1483,1449, 1404, 1314, 1131,
1073,958, 913,834, 758, 686, 666 cmꢀ1; 1H NMR (CDCl3,
400MHz, TMS) δ: 9.30 (s, 1H), 8.20ꢀ8.14 (m, 3H), 8.04 (d,
°C; IR (KBr) max = 3362, 2923, 1742, 1692, 1637, 1561, 1528, 90 J=8.92Hz, 1H), 7.68 (dd, J=2.16, 8.84Hz, 1H), 7.58ꢀ7.55 (m,
1
1275, 1155, 750 cmꢀ1; H NMR (CDCl3, 400MHz, TMS) δ: 8.78
(bs, 1H), 8.06 (d, J=7.56Hz, 3H), 7.67 (t, J=7.36Hz, 1H), 7.56 (t,
35 J=7.56Hz, 2H), 7.33 (d, J=8.52Hz, 1H), 6.75 (d, J=8.6Hz, 1H),
4.78 (d, J=4.28Hz, 2H), 2.31 (s, 3H); 13C NMR (CDCl3, 100MHz,
3H); 13C NMR (CDCl3, 100MHz, TMS) δ: 152.48, 143.38,
142.62, 140.07, 136.27, 136.07, 130.56, 130.48, 130.34, 129.21,
128.95, 128.49, 127.84, 127.60; MS (ESI) m/z: 240 (M)+.
7ꢀChloroꢀ2ꢀ(4ꢀmethoxyphenyl)quinoxaline (Table 8, Entry
TMS) δ: 192.91, 142.19, 137.62, 134.52, 134.17, 132.33, 129.03, 95 7)5i: Offꢀwhite solid (216 mg, 80 %); mp = 103ꢀ105 °C; IR (KBr)
127.89, 126.44, 125.59, 114.12, 49.55, 20.01; MS (APCI) m/z:
271 (M+H)+. HRMS (ESI) m/z calcd for C15H14N2O3Na+
40 [M+Na+], 293.0897; Found 293.0785.
= 2922, 1607, 1539, 1487, 1258, 1225, 1181, 1125, 1071,
max
1025, 957, 914, 841, 827, 750, 571, 515 cmꢀ1; H NMR (CDCl3,
400MHz, TMS) δ: 9.30 (d, J=5.92Hz, 1H), 8.19 (dd, J=3.04,
8.76Hz, 2H), 8.12 (dd, J=2.12, 10.88Hz, 1H), 8.08ꢀ8.03 (m, 1H),
1
1ꢀ(4ꢀMethoxyphenyl)ꢀ2ꢀ[(4ꢀmethylꢀ2ꢀ
nitrophenyl)amino]ethanone (Table 3, Entry 6): Yellowish 100 7.73ꢀ7.66 (m, 1H), 7.10 (d, J=8.72Hz, 2H), 3.93 (s, 3H); 13C
orange solid (270 mg, 90 %); mp = 128ꢀ130 °C; IR (KBr)
=
NMR (CDCl3, 100MHz, TMS) δ: 161.77, 143.88, 143.15,
135.97, 131.21, 130.61, 130.29, 130.00, 129.10, 128.99, 128.79,
128.28, 128.03, 114.68, 55.49; MS (APCI) m/z: 271 (M+H)+.
HRMS (ESI) m/z calcd for C15H11ClN2ONa+ [M+Na+], 293.0452;
max
3364, 2912, 1676, 1632, 1600, 1560, 1524, , 1424, 1348, 1262,
1
45 1241, 1181, 764 cmꢀ1; H NMR (CDCl3, 400MHz, TMS) δ: 8.75
(bs, 1H), 8.01 (s, 2H), 7.99 (d, J=1.96Hz, 1H), 7.28 (dd, J=2,
14.5Hz, 1H), 6.99 (d, J=1.9Hz, 2H), 6.71 (d, J=8.6Hz, 1H), 4.68 105 Found 293.0452.
(d, J=4.4Hz, 2H), 3.88 (s, 3H), 2.27 (s, 3H); 13C NMR (CDCl3,
100MHz, TMS) δ: 191.31, 164.26, 142.30, 137.59, 132.32,
50 132.20, 127.51, 126.42, 125.42, 114.18, 113.75, 55.61,49.15,
20.00; MS (ESI) m/z: 301 (M+H)+. HRMS (ESI) m/z calcd for
C16H16N2O4Na+ [M+Na+], 323.1008; Found 323.1005.
7ꢀChloroꢀ2ꢀ(4ꢀchlorophenyl)quinoxaline (Table 8, Entry 8):
Light orange solid (225 mg, 82 %); mp = 180ꢀ182 °C; IR (KBr)
1
= 2922, 1521, 1275, 1260, 1022, 764, 750 cmꢀ1; H NMR
max
(CDCl3, 400MHz, TMS) δ: 9.30 (s, 1H), 8.18ꢀ8.15 (m, 3H), 8.07
110 (d, J=8.92Hz, 1H), 7.72 (dd, J=2.32, 8.92Hz, 1H) 7.58ꢀ7.55 (m,
2H); 13C NMR (CDCl3, 100MHz, TMS) δ: 151.30, 142.92,
142.56, 140.17, 137.01, 136.33, 134.70, 131.53, 130.77, 130.39,
129.48, 128.82, 128.73, 128.45; MS (APCI) m/z: 275 (M+H)+.
HRMS (ESI) m/z calcd for C14H8Cl2N2Na+ [M+Na+], 296.9957;
2ꢀ(4ꢀMethoxyphenyl)quinoxaline (Table 8, Entry 2)5k: Light
yellow solid (377 mg, 83 %); mp = 97ꢀ98 °C; IR (KBr)
=
max
1
55 2926, 1606, 1584, 1274, 1252, 1175, 1028, 834, 763 cmꢀ1; H
NMR (CDCl3, 400 MHz, TMS) δ: 9.28 (s, 1H), 8.18ꢀ8.07 (m,
4H), 7.76ꢀ7.67 (m, 2H), 7.08ꢀ7.04 (m, 2H), 3.87 (s, 3H); 13C 115 Found 297.1305.
NMR (CDCl3, 100MHz, TMS) δ: 161.45, 151.37, 143.04,
2ꢀ(4ꢀBromophenyl)ꢀ7ꢀchloroquinoxaline (Table 8, Entry 9)5c:
8
| Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]